Endpoints News May 19, 2026 Another Paragon offshoot chooses reverse merger, this time for migraine drugs
Endpoints News May 19, 2026 Relay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
Endpoints News May 19, 2026 BioMarin's rare disease therapy shows no clinical benefit in Phase 3 test
Endpoints News May 18, 2026 Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report
Endpoints News May 18, 2026 Design Therapeutics' Friedreich's ataxia data; Vincentage's obesity results from China
Endpoints News May 18, 2026 FDA approves AstraZeneca’s baxdrostat for certain patients with hypertension